Fosgerau Consult ApS

Fosgerau Consult (FC) is a small and flexible team of seasoned professionals that aims to deliver personal consulting within Drug Development processes and Life Science business development. We possess strong and broad experience across the value chain of Drug Development and offer assistance of both A) strategic and B) specialised nature. A) - Drug development processes: target exploration, screening cascade, hit generation, lead characterisation - Partnering strategies and business development: project selection, pitch decks, VC/pharma interaction - IP strategies: drafting of patents, patent strategy - Due diligences and project evaluations: Technical feasibility, project plans, target evaluation, indication fit B) - Project management (research, Non-clinical) - Peptide chemistry and design - In vivo pharmacology models and study design with a focus on metabolic diseases - Pharmaceutical sciences, in vitro pharmacology, PK/PD pharmacology, tox and safety studies, etc. References: Sygnature Discovery, Unikum Tx, Teitur Trophics, Insusense Tx, UCPH and others. “FC has been providing strategic level consultative advice around our in-vivo pharmacology service solutions. The scientific input particularly around metabolic and fibrotic disease models has been particularly helpful. FC provided some great advice around clear endpoints and study design. We would certainly recommend their consultative services.” - Paul Overton, Sygnature "Together with FC, Teitur has been advancing our lead program, focusing on Huntington’s disease. In this respect, FC has provided both scientific and IP strategic input. We have been especially impressed by the hands-on approach which has been really pivotal for our progress. FC does not only support the project management for our lead program, but also provides an expert understanding of the path ahead. We continue to be impressed and strongly recommend FC." - Simon Mølgaard, Teitur